Emerging Trends and Growth Drivers in the Quantitative Polymerase Chain Reaction (qPCR) Instruments Market Through 2029
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Does the Forecast Indicate for the Quantitative Polymerase Chain Reaction (qPCR) Instruments Market From 2025 to 2029?
In past years, the market size for quantitative polymerase chain reaction (qPCR) tools has seen notable expansion. It is anticipated to grow from $1.51 billion in 2024 to $1.66 billion in 2025, at a compound annual growth rate (CAGR) of 10.4%. This growth in the historical period is mainly due to an increased incidence of chronic illnesses, the growing use of qPCR in genetic and genome research, the rise in private and public investment in life sciences, the increasing acceptance of point-of-care diagnostic tools, and a rise in demand for high-efficiency testing systems.
A rapid expansion in the quantitative polymerase chain reaction (qPCR) instruments market is expected in the upcoming years, projected to reach $2.45 billion by 2029 with a compound annual growth rate (CAGR) of 10.2%. Factors contributing to this surge during the forecast period include a higher incidence of infectious diseases, an increasing demand for personalized medical care, the growing application of qPCR in the field of oncology, the rising adoption of qPCR in clinical labs, and an intensified focus on early disease detection. Key trends for the forecast period include advancements in qPCR platforms, the incorporation of automation technologies, progress in microfluidics, the creation of multiplex qPCR technologies, and the inclusion of cloud-based data management systems.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25890&type=smp
What Elements Are Contributing To Growth In The Quantitative Polymerase Chain Reaction (qPCR) Instruments Market?
The rise in infectious diseases is predicted to fuel the expansion of the quantitative polymerase chain reaction (qPCR) instruments market. Infectious diseases, triggered by harmful microorganisms like bacteria, viruses, fungi, or parasites, can spread directly or indirectly among people. The proliferation of these diseases is linked to the increase in global travel, which allows pathogens to swiftly move across boundaries. Quantitative polymerase chain reaction (qPCR) instruments help in fighting infectious diseases by permitting quick, sensitive, and accurate pathogen detection, which aids in immediate diagnosis and effective disease treatment. For example, GOV.UK, a UK-based government division, recorded that the count of tuberculosis (TB) incidences in England rose from 4,380 in 2022 to 4,850 in 2023. Consequently, the escalating prevalence of infectious diseases is propelling the growth of the quantitative polymerase chain reaction (qPCR) instruments market.
Which Segments Are Detailed In The Global Quantitative Polymerase Chain Reaction (qPCR) Instruments Market Report?
The quantitative polymerase chain reaction (qpcr) instruments market covered in this report is segmented –
1) By Product Type: Quantitative Polymerase Chain Reaction Systems, Reagents And Consumables, Software
2) By Instrument: 7500, Viia 7 Dx, Cobas 4800, Cfx96, Smartcycler, Genexpert, Rotor-Gene Q, Rotor-Gene Q 5plex Hrm System, Biofire Filmarray Systems, Other Instruments
3) By Application: Gene Expression, Genotyping, Pathogen Detection, Diagnostics, Other Applications
4) By End-Users: Diagnostic Laboratories, Hospitals And Clinics, Pharma And Biotech Companies, Other End-Users
Subsegments:
1) By Quantitative Polymerase Chain Reaction (qPCR) Systems: Real-Time Polymerase Chain Reaction Systems, Portable Or Compact qPCR Devices, Digital Polymerase Chain Reaction Systems
2) By Reagents And Consumables: Master Mixes, Buffers And Enzymes, Primers
3) By Software: Data Analysis Software, Cloud-Based Analytics Platforms, Instrument Control Software
Which Trends Are Redefining The Future Landscape Of The Quantitative Polymerase Chain Reaction (qPCR) Instruments Industry?
Major players in the quantitative polymerase chain reaction (qPCR) equipment industry are emphasizing on introducing innovative solutions, including next-gen qPCR systems, in order to enhance test accuracy, augment operational efficiency, and solidify their market status in the diagnostic sector. The term next-gen qPCR platform denotes an advanced molecular diagnostic mechanism aimed to offer high sensitivity, quicker processing, wider multiplexing, and more extensive automation, which leads to improved testing accuracy and precision. For example, Roche Holding AG, a pharmaceutical firm based in Switzerland, launched the LightCycler PRO System, which offers enhanced qPCR capabilities with better speed, accuracy, and automatic functions. It assures trustworthy, adaptable, and efficient real-time PCR outcomes for both clinical and research utilizations, armed with progressive multiplexing elements, easy-to-use software, and accurate temperature regulation for consistent outcomes. The system’s prominent advantages involve a swift amendment to evolving test requirements, optimized workflows with simplified data management, and a superior user interface encompassing a larger touchscreen and smooth system amalgamation.
Who Are The Key Contributors To Growth In The Quantitative Polymerase Chain Reaction (qPCR) Instruments Market?
Major companies operating in the quantitative polymerase chain reaction (qpcr) instruments market are F. Hoffmann-La Roche AG., Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickinson and Company, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Eppendorf SE, Cepheid Inc., Takara Bio Inc., bioMérieux SA, Analytik Jena GmbH, Standard BioTools Inc., Hangzhou Bioer Technology Co. Ltd., BioTeke Corporation, GeneReach Biotechnology Corp., Anitoa Systems LLC, Blue-Ray Biotech Corp., Chai Biotechnologies, Bio Molecular Systems Pty Ltd., Azure Biosystems Inc.
Get The Full Report Here:
Which Region Is Projected To Lead The Quantitative Polymerase Chain Reaction (qPCR) Instruments Market By 2025?
North America was the largest region in the quantitative polymerase chain reaction (qPCR) instruments market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the quantitative polymerase chain reaction (qpcr) instruments market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=25890&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
